XML 23 R12.htm IDEA: XBRL DOCUMENT v3.26.1
Note 7 - Stock-based Compensation
6 Months Ended
Mar. 28, 2026
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

(7) Stock-Based Compensation

 

Under our equity incentive plan, employees and directors may be granted stock options, restricted stock, restricted stock units and performance awards. Effective February 11, 2025, the shareholders of the Company approved the 2025 Equity Incentive Plan of Insteel Industries Inc. (the “2025 Plan”), which authorizes the issuance of up to 800,000 shares of our common stock, plus any shares remaining available for grant under the 2015 Equity Incentive Plan of Insteel Industries Inc. (as amended, the “2015 Plan”) as of the effective date of the 2025 Plan and any shares subject to an award granted under the 2015 Plan which are forfeited, cancelled, terminated, lapsed or expired without the issuance of shares. The 2025 plan expires on February 10, 2035. As of March 28, 2026, there were 821,000 shares of our common stock available for future grants under the 2025 Plan, which is our only active equity incentive plan.

 

Stock option awards. Under the 2025 Plan, employees and directors may be granted options to purchase shares of common stock at the fair market value on the date of the grant. Options granted under the 2025 Plan generally vest over three years and expire ten years from the date of the grant. Compensation expense associated with stock options was $570,000 and $569,000 for the three-month periods ended March 28, 2026, and March 29, 2025, respectively, and $706,000 and $696,000 for the six-month periods ended March 28, 2026, and March 29, 2025, respectively. As of March 28, 2026, there was $745,000 of unrecognized compensation cost related to unvested options which is expected to be recognized over a weighted average period of 2.21 years.

 

The following table summarizes stock option activity:

 

                   

Contractual

   

Aggregate

 
   

Options

   

Weighted

   

Term - Weighted

   

Intrinsic

 
   

Outstanding

   

Average

   

Average

   

Value

 
   

(in thousands)

   

Exercise Price

   

(in years)

   

(in thousands)

 

Outstanding at September 27, 2025

    524     $ 32.01                  

Granted

    49       37.00                  

Exercised

    (3 )     32.15             $ 15  

Outstanding at March 28, 2026

    570       32.44       6.69       1,378  
                                 

Vested and anticipated to vest in the future at March 28, 2026

    557       32.39       6.63       1,372  
                                 

Exercisable at March 28, 2026

    360       31.41       5.35       1,248  

 

Stock option exercises include “net exercises” for which the optionee received shares of common stock equal to the intrinsic value of the options (fair market value of common stock on the date of exercise less exercise price) reduced by any applicable withholding taxes.

 

Restricted stock units. Restricted stock units (“RSUs”) granted under the 2025 Plan are valued based upon the fair market value on the date of the grant and provide for a dividend equivalent payment which is included in compensation expense. The vesting period for RSUs is generally one year from the date of the grant for RSUs granted to directors and three years from the date of the grant for RSUs granted to employees. RSUs do not have voting rights. Compensation expense associated with RSUs was $747,000 and $774,000 for the three-month periods ended March 28, 2026 and March 29, 2025, respectively, and $1.1 million and $992,000 for the six-month periods ended March 28, 2026, and March 29, 2025, respectively.

 

As of March 28, 2026, there was $1.5 million of unrecognized compensation cost related to unvested RSUs which is expected to be recognized over a weighted average period of 1.64 years.

 

 

The following table summarizes RSU activity:

 

           

Weighted

 
   

Restricted

   

Average

 
   

Stock Units

   

Grant Date

 

(Unit amounts in thousands)

 

Outstanding

   

Fair Value

 

Balance, September 27, 2025

    147     $ 32.31  

Granted

    34       37.00  

Vested

    (44 )     30.95  

Balance, March 28, 2026

    137       33.91